首页> 外文期刊>中国药理学报:英文版 >雌激素功能性调节人内皮细胞的生长调节致癌基因α表达
【24h】

雌激素功能性调节人内皮细胞的生长调节致癌基因α表达

机译:雌激素功能性调节人内皮细胞的生长调节致癌基因α表达

获取原文
获取原文并翻译 | 示例
           

摘要

目的:研究雌激素在体外调节人脐带静脉内皮细胞rn(HUVEC)的生长调节致癌基因α(GROα).方法:rn以体外培养的HUVEC为模型,Northern法检测CXCrn族趋化因子GROα mRNA;ELISA方法检测细胞表面rn的GROα蛋白表达;静态细胞粘附实验测定细胞表rn面的GROα蛋白的生理意义. 结果:17β-雌二醇rn(0.05 μmol/L)明显抑制HUVEC产生GROα mRNArn和蛋白表达水平;而且17β-雌二醇抑制其蛋白表达rn水平显示剂量依赖性关系;雌激素受体α拮抗剂rn他莫昔芬(0.1 μmol/L)单独使用不影响其蛋白表达,rn但可显著逆转17β-雌二醇抑制的GROα蛋白表达,rn显著逆转17β-雌二醇抑制单核细胞系细胞U937细胞rn粘附到HUVEC的作用达.结论:通过内皮细胞上rn雌激素受体α,雌激素可能功能性调节人内皮细胞rn的GROα的表达.%AIM: To study the effect of estrogen on expression of rngrowth-regulated oncogene α (GROα) in human umbilical rnvein endothelial cells (HUVEC) in vitro. METHrnODS: Expressions of CXC chemokine GROα mRNA and rnprotein were measured by Northern blotting assay and rnELISA, respectively. The physiological significance of rnGROα expression was tested by static cell adhesion assay.rnRESULTS: Both the GROα mRNA and protein levels rndecreased markedly after HUVEC were exposured to rn17β-estradiol (E2) 0.05 μmol/L. Moreover, the inhibirntion of the protein was depended on the concentration of rn17β-estradiol. Tamoxifen (0.1 μmol/L), an estrogen rnreceptor α antagonist, alone did not affect GROα protein rnexpression, but can reverse the E2-induced inhibition of rnGROα protein expression (by up to 50 % ) and the rnbinding of U937 cells to E2-treated HUVEC (by up to rn40 % ). CONCLUSION: Estrogen might functionally rndown-regulates GROα expression through estrogen rnreceptor α on endothelial cells.
机译:目的:研究雌激素在体外调节人脐带静脉内皮细胞rn(HUVEC)的生长调节致癌基因α(GROα).方法:rn以体外培养的HUVEC为模型,Northern法检测CXCrn族趋化因子GROα mRNA;ELISA方法检测细胞表面rn的GROα蛋白表达;静态细胞粘附实验测定细胞表rn面的GROα蛋白的生理意义. 结果:17β-雌二醇rn(0.05 μmol/L)明显抑制HUVEC产生GROα mRNArn和蛋白表达水平;而且17β-雌二醇抑制其蛋白表达rn水平显示剂量依赖性关系;雌激素受体α拮抗剂rn他莫昔芬(0.1 μmol/L)单独使用不影响其蛋白表达,rn但可显着逆转17β-雌二醇抑制的GROα蛋白表达,rn显着逆转17β-雌二醇抑制单核细胞系细胞U937细胞rn粘附到HUVEC的作用达.结论:通过内皮细胞上rn雌激素受体α,雌激素可能功能性调节人内皮细胞rn的GROα的表达.%AIM: To study the effect of estrogen on expression of rngrowth-regulated oncogene α (GROα) in human umbilical rnvein endothelial cells (HUVEC) in vitro. METHrnODS: Expressions of CXC chemokine GROα mRNA and rnprotein were measured by Northern blotting assay and rnELISA, respectively. The physiological significance of rnGROα expression was tested by static cell adhesion assay.rnRESULTS: Both the GROα mRNA and protein levels rndecreased markedly after HUVEC were exposured to rn17β- estradiol (E2) 0.05 μmol/L. Moreover, the inhibirntion of the protein was depended on the concentration of rn17β-estradio l. Tamoxifen (0.1 μmol/L), an estrogen rnreceptor α antagonist, alone did not affect GROα p​​rotein rnexpression, but can reverse the E2-induced inhibition of rnGROα p​​rotein expression (by up to 50 % ) and the rnbinding of U937 cells to E2-treated HUVEC (by up to rn40 % ). CONCLUSION: Estrogen might functionally rndown-regulates GROα expression through estrogen rnreceptor α on endothelial cells.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号